Texas Instruments Incorporated

Overview

An investment analysis of Texas Instruments (NASDAQ: TXN) in the style of William J. O’Neil’s CAN SLIM, using the latest structured financials and corroborated earnings/news to assess fundamentals, competitive position, price/volume action, and catalysts/risks.

Financial and Business Overview

Texas Instruments is a leading analog and embedded processing semiconductor company serving industrial and automotive end markets. 2024 revenue was $15.64B (-10.7% YoY) and TTM revenue has recovered to ~$16.7B with TTM gross margin ~58% and net margin ~30% (consistent with analog peers). Q3 2025 revenue was $4.74B (+14% YoY) with EPS $1.48 (roughly flat YoY, +$0.01), and Analog segment revenue +16% YoY. Guidance for Q4 2025 implies a softer quarter (revenue $4.22–$4.58B; EPS $1.13–$1.39). Trailing EPS is $5.46 (forward EPS ~$5.88); trailing P/E ~30.4x; forward P/E ~28.3x. The dividend was raised to $1.42 quarterly ($5.68 annual; ~3.1% yield). TTM cash from operations is ~$6.9B; TTM free cash flow ~$2.4B, depressed by heavy 300mm fab CapEx (~$4.8B TTM). Long-term debt was ~$12.8B at YE 2024 (rising to ~$13.5B by Q3 2025), with a strong liquidity profile (current ratio ~4x) but elevated inventories as TXN ramps internal capacity. Management continues a multi-year US manufacturing build-out (300mm Sherman TX, Lehi UT), supported by CHIPS Act incentives, aiming for cost leadership and supply-chain resilience.

Market Position & Competitive Advantages

TXN holds a top global share in analog semis with a very broad catalog, deep customer relationships, long product life cycles, and vertical integration in 300mm manufacturing—key cost and availability advantages. End-market mix skews toward industrial and automotive, providing diversified, durable demand. Risks: (1) earnings cyclicality tied to industrial/auto cycles; (2) near-term margin/FCF compression from high CapEx and rising depreciation; (3) potential pricing pressure from low-cost competitors (notably in China) in commoditizing analog categories; (4) tariff/trade policy frictions that can weigh on demand; and (5) inventory normalization dynamics at customers. While Q3 showed broad-based revenue growth, the Q4 outlook indicates the recovery remains uneven. Over a full cycle, TXN’s scale, 300mm cost structure, and distribution strength support durable margins and returns, but current valuation embeds a fair amount of recovery.

Stock Performance

Price: $166.22 (as of 2025-10-22). 52-week range: $139.95–$221.69; shares are ~25% below the 52-week high and ~19% above the low. 50-day average ~$186.73 and 200-day average ~$186.18—price is below both, indicating a downtrend. 1-year change ~-10% to -11% vs US semiconductor industry’s strong gains, signaling relative underperformance. Average analyst target price clusters around ~$201–$205, implying ~20% upside from the structured price, but near-term guidance drove a post-earnings pullback amid heavy volume.

CAN SLIM Analysis

Conclusion

From a CAN SLIM perspective, TXN lacks key buy triggers: quarterly EPS growth is modest, annual EPS trend has not yet re-accelerated, and shares are below major moving averages without a breakout. However, for long-term investors, TXN’s durable analog franchise, 300mm cost advantage, diversified industrial/auto exposure, and a 3.1% dividend yield argue against selling into weakness. Maintain a HOLD, monitor for: (1) evidence of sustained EPS re-acceleration (e.g., quarterly EPS growth >25% with broad revenue strength), (2) improving free cash flow as CapEx normalizes and depreciation is absorbed, (3) a new base and breakout above the 50/200-day MAs on higher volume (potential pivot area ~190–195), and (4) confirmation of a market uptrend. Accumulate only on a technically proper breakout with improving earnings momentum.